The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide - Wikidata - wikimedia - TriplyDB

The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide

The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide

http://www.wikidata.org/entity/Q35633490

about

Transient receptor potential (TRP) channels and cardiac fibrosis Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.Aging and Cardiac Fibrosis.Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.Myocardial T1 mapping: techniques and potential applications.Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling.Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population.Cardiac aging: from molecular mechanisms to significance in human health and disease Mitochondria and the aging heart.Cardiac micro-computed tomography imaging of the aging coronary vasculature.CNP Signal Peptide in Patients with Cardiovascular Disease.Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.The Living Scar--Cardiac Fibroblasts and the Injured Heart.Cardiorenal fibrosis and dysfunction in aging: Imbalance in mediators and regulators of collagen.Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study.Aerobic vs anaerobic exercise training effects on the cardiovascular system.Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.Heart failure treatment in the elderly.M-atrial natriuretic peptide: a novel antihypertensive protein therapy.Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.Molecular Physiology of Membrane Guanylyl Cyclase Receptors.Urinary C-type natriuretic peptide excretion: a promising biomarker to detect underlying renal injury and remodeling both acutely and chronically.Cardiac fibrosis in the ageing heart: contributors and mechanisms.Atrial structure, function and arrhythmogenesis in aged and frail mice.The alteration of NTproCNP plasma levels following anaerobic exercise in physically active young men.Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.Aging does not affect radial viscoelastic behavior of the left ventricle.Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats.Relaxin reverses inflammatory and immune signals in aged hearts.Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.Effects of gene knockdown of CNP on ventricular remodeling after myocardial ischemia-reperfusion injury through NPRB/Cgmp signaling pathway in rats.The impacts of age and frailty on heart rate and sinoatrial node function.Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans.Arrhythmias in Patients ≥80 Years of Age: Pathophysiology, Management, and Outcomes.

P2860

Q24625500-D97FC1C8-E7AB-4A36-93CC-2BDCC735AC25 Q26778333-29938C12-63D4-42AF-AAAC-9F32CC72AD11 Q34150487-DEF4DDCC-21CD-4415-9157-30DD5F990798 Q34526136-152FB6DB-6409-4A72-A60E-ECFB95FD3DAA Q35155965-372A255B-5A72-4ACB-842C-A926E7DB6508 Q35164124-14E8496E-1D44-46FA-9230-40C1E7745B00 Q35174325-39052545-C5CD-46DF-A3BB-5A555393F45D Q35538390-25980662-990A-4721-BFF0-F2A084BC114C Q35543215-F72950F7-6183-457F-96CB-3F532F0F7D1D Q35611405-4EC53416-02CC-4BB0-8A00-927CDFB0060D Q35898648-AE22FFEC-6396-459E-B307-DFB0D175471F Q36077249-30B3C0CC-90DD-4C21-938C-2F991CB50682 Q36126790-29A66117-FB62-45AB-8313-8FA99107B2CF Q36351139-4F01B276-7DDE-4446-883C-F948A1479D83 Q36528021-290D2FAD-2993-49CB-AAEB-BA011BC077F1 Q36535178-59ACA8AB-2082-4042-A3C3-2450098A4427 Q36584049-2DA2FA02-A755-4A47-ABAE-59F0CA8AAAA6 Q36860608-078DB8B0-9F3A-4633-8B88-6BBEBBEFA170 Q37505066-003D162A-5411-41DF-BE1E-305B87C38067 Q37670949-127BA5B1-6FFC-4820-9460-0598CED1939C Q37694008-B8AE8350-02FB-48C8-B6AF-5A00E94D154D Q37914058-44B6E8CE-92DC-49F7-AF48-40D16B156D61 Q37935778-96F1CCC3-428F-4D47-9B0B-962C884ABEAE Q37963837-F6CB971A-C3C6-439F-A1B7-4D45ED5EFBDD Q38261513-0834A545-B7BE-488B-9E8C-9B8B5FCFF8EB Q38605457-7C8D3EE5-AA30-448E-8397-90C015787ED5 Q38794203-DC60CEE3-8D39-45AB-8583-94D5C88CDA8F Q38825225-A387CB9D-1D80-4EDB-B853-FF8E2810E133 Q39186232-2935E179-D18A-4CF4-86B1-A2E30F613F9F Q42074972-993D015D-C74E-420E-893A-7A94C5DF80B5 Q42078351-9B23DB7D-8836-4332-81E1-F060F0A7E068 Q44710575-84712346-F602-49AD-8DBF-BF9B51D69352 Q45343339-ADF4DADF-59BF-4D16-8A81-2FE155445A5A Q46335588-DB2655DA-5B2B-4EFB-B4F0-0567F1C32BF5 Q47551745-8B6AF936-E92E-4021-986A-75A5B33E40A1 Q47855200-43CD98D9-FCAB-4161-AEDD-05BF575DB064 Q48259695-5C1BD1C0-59AF-4ACD-B942-28E783CD985B Q51171807-8EC9CDEB-E8FE-47C9-AF24-F94159CD1DFE Q51360442-4923F129-6A8A-433D-9516-C0B9A92949BF Q55380343-08A99564-193E-48D5-B457-00116F78DF42

P2860

The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide

http://www.wikidata.org/entity/Q35633490

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

The aging heart, myocardial fi ...... ing C-type natriuretic Peptide

@ast

The aging heart, myocardial fi ...... ing C-type natriuretic Peptide

@en

type

label

The aging heart, myocardial fi ...... ing C-type natriuretic Peptide

@ast

The aging heart, myocardial fi ...... ing C-type natriuretic Peptide

@en

prefLabel

The aging heart, myocardial fi ...... ing C-type natriuretic Peptide

@ast

The aging heart, myocardial fi ...... ing C-type natriuretic Peptide

@en

P1433

Q35633490-963CF552-67E3-418E-892C-61F628EF759B

P1476

Q35633490-D1501B20-9789-4EE2-B737-6CF4A78FEFAD

P2093

Q35633490-62788274-F2AE-401B-AAD0-A7EDDAE597B9

Q35633490-6DA9993A-FE47-4327-B5FD-6E153B29F406

Q35633490-72AA5224-81EA-485B-A78E-C3D157BED205

Q35633490-8AA31D59-FEC2-4B04-B607-591C544E7D96

Q35633490-963567B7-C663-4865-BC66-23CD91D7D3C5

Q35633490-974A0676-A695-48C9-808A-A03448C10577

Q35633490-E81EFA89-BD1E-47EA-A727-3FE1F1F33841

Q35633490-F861A28B-6DC3-4096-947A-30B007AA4A66

Q35633490-F89ADB6F-EE71-4922-A414-5EE222C656A1

P2860

Q35633490-019FB6C5-B212-4330-BDF8-8A77BBA2A1E9

Q35633490-0AED5E28-B485-4ECB-9D68-5C7851F019F2

Q35633490-17363B14-1EE7-4E89-AAB4-357FCAF21D1E

Q35633490-18D83FA1-F6F0-44F1-B3E3-D4F8189EFF23

Q35633490-1C55D40F-9C94-434D-9405-4B91B7A86628

Q35633490-1CC5A647-49E5-4CB4-BFC2-25BA7BABA840

Q35633490-237FB117-0045-482A-89B5-67C989BA3ABB

Q35633490-26E5A11B-8937-4AEA-803A-6085706BEDFA

Q35633490-2926FD46-0D9D-4702-BBC7-61E42F03AC2E

Q35633490-2D68C4F4-BE67-42F4-8DBA-EC157517203B

P304

Q35633490-F84D0687-54F5-4BC6-9B6E-1EAF355CF308

P31

Q35633490-F31AD445-CC7F-45F4-89A7-E76FBCE9A58A

P356

Q35633490-6C6FA460-DC68-43C6-8B7D-436BAF74A7A0

P407

Q35633490-3BC1B483-49D6-46CA-8430-338CE0C10E7E

P433

Q35633490-B1AB20F5-F8EB-4762-80D0-AC6A69367720

P478

Q35633490-E02C1370-4B4F-4C63-9699-FDC3DBBB9A63

P577

Q35633490-DF95A8CC-E9DB-4F96-95EB-5178F68393F8

P5875

Q35633490-35C7DAF6-CDBA-458A-A436-123F6908CA75

P698

Q35633490-98D0B215-49A7-434B-81A5-76001EF23B62

P921

Q35633490-B2DA7F09-1766-418C-80C4-B856FD8D4A7D

P932

Q35633490-B1F45DB5-F6EC-4F6C-AAC7-976926BDD4ED

P356

HYPERTENSIONAHA.110.160796

P1433

P1476

The aging heart, myocardial fi ...... ing C-type natriuretic Peptide

@en

P2093

Brenda K Huntley

http://www.w3.org/2001/XMLSchema#string

Diego Bellavia

http://www.w3.org/2001/XMLSchema#string

Fernando L Martin

http://www.w3.org/2001/XMLSchema#string

Gerald E Harders

http://www.w3.org/2001/XMLSchema#string

Horng H Chen

http://www.w3.org/2001/XMLSchema#string

John C Burnett

http://www.w3.org/2001/XMLSchema#string

Paul M McKie

http://www.w3.org/2001/XMLSchema#string

S Jeson Sangaralingham

http://www.w3.org/2001/XMLSchema#string

Tomoko Ichiki

http://www.w3.org/2001/XMLSchema#string

P2860

Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)

Natriuretic peptide system in human heart failure

The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging

Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts

Dwarfism and early death in mice lacking C-type natriuretic peptide

TGF-beta Sma/Mab signaling mutations uncouple reproductive aging from somatic aging.

Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor.

Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide.

Plasma brain natriuretic peptide concentration: impact of age and gender.

P304

201-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.110.160796

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49712796

http://www.w3.org/2001/XMLSchema#string

P698

21189408

http://www.w3.org/2001/XMLSchema#string

P921

C-Type natriuretic peptide

P932

4440480

http://www.w3.org/2001/XMLSchema#string